English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 11, 2026

TrumpRx platform launching Thursday aims to offer discounted cash drug prices

+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Biotech sector sees revival in IPO activity led by Eikon Therapeutics' record offering

+ Pharmaceuticals
Patient Daily | Feb 11, 2026

ENT & Allergy Associates adds Dr. Sandra Ho to Manhasset office

+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Lifelong learning linked to improved well-being among older adults at Ohio State

+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Obesity drug market sees advances in oral therapies amid pricing deals and access concerns

+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Eli Lilly acquisition highlights surge in interest for in vivo gene therapies

+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Pelage Pharmaceuticals advances stem cell-based therapy for pattern hair loss

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

Amgen ends partnership with Kyowa Kirin on autoimmune drug rocatinlimab

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily